We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Synergy Pharmaceuticals, Inc. | NASDAQ:SGYP | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.03 | 0.0488 | 0.049 | 0 | 01:00:00 |
From Jun 2019 to Jun 2024
By Josh Beckerman
Shares of Synergy Pharmaceuticals Inc. (SGYP), which filed for bankruptcy last week, recently traded up 55% to 12 cents as the company's flagship product Trulance was accepted for review by Health Canada.
Cipher Pharmaceuticals Inc. (CPH.T) bought Canadian rights to the constipation drug in Februrary.
Synergy filed for chapter 11 on Dec. 12 with a plan to sell its assets to Bausch Health Companies Inc. (BHC) for about $200 million in cash.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
December 17, 2018 15:28 ET (20:28 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
1 Year Synergy Pharmaceuticals, Inc. Chart |
1 Month Synergy Pharmaceuticals, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
